UCB brings promising plaque psoriasis data to EADV 2018
September 14, 2018Medical Communications, Research and Development EADV 2018, UCB, pharma, psoriasis
UCB has joined in on the wave of new psoriasis data emerging from the European Academy of Dermatology and Venereology …
Pfizer, Novartis, MSD, Novo and GSK halt operations in wake of Hurricane Florence
September 14, 2018Medical Communications GSK, Hurricane Florence, MSD, Novartis, Novo Nordisk, Pfizer, pharma
As Hurricane Florence begins to breach the Southeast Coast, major pharma firms have announced they are enacting contingency plans, including …
Top Ten most popular articles on Pharmafile.com this week
September 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, FDA, NICE, Novo Nordisk, Spinraza, brexit, bristol myers squibb, top 10
With the Pharmafocus team having avoided hurricane Florence and finally arriving back in the UK just last night, after stopping …
Scottish government invests £11m into Glasgow biotechnology centre
September 14, 2018Medical Communications Biotechnology, IBioIC, Scotland, glasgow, scottish government
The Scottish government is investing £11 million into the Glasgow-based Industrial Biotechnology Innovation Centre (IBioIC), an innovation centre which facilitates …
FDA launch plan to tackle e-cig epidemic
September 14, 2018Medical Communications FDA, Scott Gottlieb, USA, e-cig, juul
The FDA have announced a plan to crack down on the so-called ‘e-cig epidemic’, following revelations that vaping and use …
Living with fibromyalgia
September 13, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing fibromyalgia, patient experience
Scottish comedian Carina MacLeod recounts her life with fibromyalgia and the benefits of comedy in dealing with a chronic condition, …
Oxford Biomedica to expand with fourth site, creating 100 jobs
September 13, 2018Oxford BioMedica, pharma
Gene and cell therapy group Oxford Biomedica has announced plans to expand its business with a new site located not …
Novartis doubles down on Cosentyx’s efficacy in psoriasis with extensive real-world data
September 13, 2018Research and Development Cosentyx, Novartis, pharma, psoriasis
Novartis was yet another company to reveal new data on a psoriasis drug at the European Academy of Dermatology and …
Celgene’s Otezla produces “meaningful benefits” beyond traditional metrics in plaque psoriasis
September 13, 2018Research and Development Celgene, otezla, pharma, psoriasis
Celgene made its voice heard amongst the chorus of new psoriasis data emerging from the European Academy of Dermatology and …
Phase 3 data presents strong case for switching from Humira to Janssen’s Tremfya in plaque psoriasis
September 13, 2018Research and Development Humira, Janssen, Tremfya, pharma, psoriasis
Janssen has unveiled new Phase 3 data derived from two separate trials on the efficacy and benefits of switching to …
Takeda set to move from Deerfield Illinois, 1000 jobs affected
September 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jobs, Shire, Takeda, deerfield, illinois
Japanese multinational Takeda is set to shut down its US headquarters in Deerfield, Illinois following the final stages of its …
Teva names new President, TAPI and Biologics Operations
September 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Novartis, Teva, appointment
Israeli generic drug specialist Teva has announced its appointment of John Nason in a multi-faceted role as President of Teva …
Merck KGaA and Pfizer’s combo impresses in first-line treatment of advanced kidney cancer
September 12, 2018Research and Development, Sales and Marketing Cancer, Kidney cancer, Merck KGaA, Pfizer, pharma
Bavencio (avelumab), Merck KGaA and Pfizer’s human anti-programmed death ligand-1 (PD-L1) antibody, combined with the latter’s Inlyta (axitinib) has shown …
BMS’ investigational psoriasis drug hits primary endpoint in skin clearance at Phase 2
September 12, 2018Research and Development BMS, BMS-986165, Bristol-Myers Squibb, pharma, psoriasis
Bristol-Myers Squibb has unveiled new Phase 2 data for its investigational oral, selective tyrosine kinase 2 (TYK2) inhibitor, known as …
More effective flu vaccine could prevent hundreds of elderly deaths across UK this winter
September 12, 2018Medical Communications, Research and Development NHS, Vaccine, flu, influenza, pharma
Public Health England has revealed that an enhanced, “adjuvanted” vaccine is to be made available for over-65s this winter, and …
UK Health Secretary Matt Hancock rallies against ‘rip off’ pharma companies
September 11, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Matt Hancock, NICE, Vertex, pharma, pricing
British Health Secretary Matt Hancock has said that pharmaceutical companies are trying to “rip off taxpayers” and that big business …
Protesters in Manchester call on NICE to approve Biogen’s $750,000 drug Spinraza
September 11, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, Spinraza, approval, protest, sma
Protesters in Manchester have called on the National Institute of Health and Care Excellence (NICE), to overturn their rejection of …
UK health improving but challenges of an ageing population remain, says PHE report
September 11, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Public Health England, UK, pharma
A new report from Public Health England (PHE) has illuminated the primary health concerns in UK society today, revealing the …
Novartis eyecare unit Alcon to set up new HQ in Geneva, Switzerland
September 11, 2018Manufacturing and Production Alcon, Novartis, eye care, pharma
Alcon, the eyecare unit of Novartis, is set to move to a new home next year, after its parent company …
PhRMA blames hospitals for rising drug prices, hospitals association responds
September 11, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, Drug pricing, PhRMA, hospitals, pharma
The American pharmaceutical industry trade lobby PhRMA has suggested that hospitals are to blame for high drug prices as the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
